(19)
(11) EP 3 137 079 A1

(12)

(43) Date of publication:
08.03.2017 Bulletin 2017/10

(21) Application number: 15786844.9

(22) Date of filing: 21.04.2015
(51) International Patent Classification (IPC): 
A61K 31/4709(2006.01)
C07D 215/24(2006.01)
(86) International application number:
PCT/US2015/026933
(87) International publication number:
WO 2015/167874 (05.11.2015 Gazette 2015/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 28.04.2014 US 201461985221 P

(71) Applicant: The J. David Gladstone Institutes
San Francisco, CA 94158 (US)

(72) Inventors:
  • XIE, Min
    Daly City, California 94158 (US)
  • DING, Sheng
    Orinda, California 94563 (US)

(74) Representative: Brasnett, Adrian Hugh et al
Mewburn Ellis LLP
City Tower 40 Basinghall Street London EC2V 5DE
City Tower 40 Basinghall Street London EC2V 5DE (GB)

   


(54) INHIBITORS OF JMJD2C AS ANTICANCER AGENTS